These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18508636)

  • 21. Effective combination therapy of deferiprone and deferoxamine for the rapid clearance of excess cardiac IRON and the prevention of heart disease in thalassemia. The Protocol of the International Committee on Oral Chelators.
    Kolnagou A; Kontoghiorghes GJ
    Hemoglobin; 2006; 30(2):239-49. PubMed ID: 16798649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major.
    Wu KH; Chang JS; Tsai CH; Peng CT
    Ann Hematol; 2004 Jul; 83(7):471-3. PubMed ID: 14658011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
    Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Roughton M; Assomull R; Nair SV; Walker JM; Pennell DJ
    Circulation; 2007 Apr; 115(14):1876-84. PubMed ID: 17372174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Right ventricular cardiac dysfunction in beta-thalassemia major.
    Koren A; Garty I; Antonelli D; Katzuni E
    Am J Dis Child; 1987 Jan; 141(1):93-6. PubMed ID: 3788890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
    Maggio A; Vitrano A; Capra M; Cuccia L; Gagliardotto F; Filosa A; Magnano C; Rizzo M; Caruso V; Gerardi C; Argento C; Campisi S; Cantella F; Commendatore F; D'Ascola DG; Fidone C; Ciancio A; Galati MC; Giuffrida G; Cingari R; Giugno G; Lombardo T; Prossomariti L; Malizia R; Meo A; Roccamo G; Romeo MA; Violi P; Cianciulli P; Rigano P
    Blood Cells Mol Dis; 2009; 42(3):247-51. PubMed ID: 19233692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Echocardiography in thalassemic patients on blood transfusions and chelation without heart failure.
    Rodrigues A; Guimarães-Filho FV; Braga JC; Rodrigues CS; Waib P; Fabron-Junior A; Tan DM; França AC; Okoshi MP; Okoshi K
    Arq Bras Cardiol; 2013 Jan; 100(1):75-81. PubMed ID: 23295250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.
    Leonardi B; Margossian R; Colan SD; Powell AJ
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):572-8. PubMed ID: 19356483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of cardiac iron overload in thalassemia major.
    Westwood M; Anderson LJ; Pennell DJ
    Haematologica; 2003 May; 88(5):481-2. PubMed ID: 12745264
    [No Abstract]   [Full Text] [Related]  

  • 29. Electrocardiographic abnormalities in thalassemia patients with heart failure.
    Mancuso L; Mancuso A; Bevacqua E; Rigano P
    Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):29-35. PubMed ID: 19275575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac abnormalities in the thalassaemia syndromes.
    Yee H; Mra R; Nyunt KM
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):414-21. PubMed ID: 6523177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI and iron-overload cardiomyopathy in thalassaemia.
    Pennell D
    Circulation; 2006 Mar; 113(11):f43-4. PubMed ID: 16552847
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study.
    Casale M; Meloni A; Filosa A; Cuccia L; Caruso V; Palazzi G; Gamberini MR; Pitrolo L; Putti MC; D'Ascola DG; Casini T; Quarta A; Maggio A; Neri MG; Positano V; Salvatori C; Toia P; Valeri G; Midiri M; Pepe A
    Circ Cardiovasc Imaging; 2015 Aug; 8(8):e003230. PubMed ID: 26253625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients.
    Wijarnpreecha K; Siri-Angkul N; Shinlapawittayatorn K; Charoenkwan P; Silvilairat S; Siwasomboon C; Visarutratna P; Srichairatanakool S; Tantiworawit A; Phrommintikul A; Chattipakorn SC; Chattipakorn N
    PLoS One; 2015; 10(6):e0130837. PubMed ID: 26083259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis.
    Koohi F; Kazemi T; Miri-Moghaddam E
    Ann Hematol; 2019 Jun; 98(6):1323-1331. PubMed ID: 30729283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Severe cardiomyopathy in a woman with intermediate beta-thalassemia. Regression of cardiac failure with desferrioxamine].
    Mancuso L; Iacona MA; Marchi S; Rigano P; Geraci E
    G Ital Cardiol; 1985 Sep; 15(9):916-20. PubMed ID: 4085735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
    Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of the cardiovascular complications of thalassemia by echocardiography.
    Walker JM; Nair S
    Ann N Y Acad Sci; 2010 Aug; 1202():165-72. PubMed ID: 20712789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.
    Tanner MA; Galanello R; Dessi C; Westwood MA; Smith GC; Nair SV; Anderson LJ; Walker JM; Pennell DJ
    J Cardiovasc Magn Reson; 2006; 8(3):543-7. PubMed ID: 16755844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.
    de Montalembert M; Ribeil JA; Brousse V; Guerci-Bresler A; Stamatoullas A; Vannier JP; Dumesnil C; Lahary A; Touati M; Bouabdallah K; Cavazzana M; Chauzit E; Baptiste A; Lefebvre T; Puy H; Elie C; Karim Z; Ernst O; Rose C
    PLoS One; 2017; 12(3):e0172147. PubMed ID: 28257476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and future treatment strategies for iron overload cardiomyopathy.
    Wongjaikam S; Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Eur J Pharmacol; 2015 Oct; 765():86-93. PubMed ID: 26291660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.